CI
WST icon

CX Institutional’s West Pharmaceutical WST Stock Holding History

CX Institutional’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477K Buy
1,328
+245
+23% +$74.9K 0.01% 490
2026
Q1 		$272K Sell
1,083
-11
-1% -$2.74K 0.01% 636
2025
Q4 		$301K Buy
1,094
+155
+17% +$42.4K 0.01% 582
2025
Q3 		$246K Buy
939
+48
+5% +$11.7K 0.01% 626
2025
Q2 		$195K Sell
891
-114
-11% -$24.4K 0.01% 633
2025
Q1 		$225K Buy
+1,005
New +$277K 0.01% 565
2022
Q3 		– Sell
-94
Closed -$28K – 1136
2022
Q2 		$28K Buy
+94
New +$30.6K ﹤0.01% 781
2021
Q4 		– Sell
-123
Closed -$52K – 905
2021
Q3 		$52K Buy
123
+18
+17% +$7.59K ﹤0.01% 572
2021
Q2 		$38K Buy
105
+59
+128% +$19.5K ﹤0.01% 616
2021
Q1 		$13K Sell
46
-4
-8% -$1.15K ﹤0.01% 740
2020
Q4 		$14K Buy
50
+37
+285% +$10.4K ﹤0.01% 686
2020
Q3 		$4K Buy
13
+2
+18% +$529 ﹤0.01% 775
2020
Q2 		$2K Buy
+11
New +$2.16K ﹤0.01% 772

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CX Institutional's WST Position: Q2 2026 in Review

CX Institutional increased its West Pharmaceutical (WST) stake by 23% in Q2 2026, buying an estimated $74.9K and bringing the position to 1,328 shares worth $477K. The position accounts for 0.01% of the portfolio, ranked #490.

CX Institutional first reported a position in WST in Q2 2020 and has held it in 13 quarters since. 118 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • CX Institutional held 1,328 shares of West Pharmaceutical worth $477K as of Q2 2026.
  • CX Institutional bought 245 West Pharmaceutical shares in Q2 2026, an estimated $74.9K.
  • West Pharmaceutical made up 0.01% of CX Institutional's portfolio in Q2 2026, its #490 holding.
  • CX Institutional first reported a position in West Pharmaceutical in Q2 2020 and has held it in 13 quarters since.
  • 118 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.